Clinical Significance of Non-invasive Skin Autofluorescence Measurement in Patients with Diabetes: A Systematic Review and Meta-analysis

Clinical Significance of Non-invasive Skin Autofluorescence Measurement in Patients with Diabetes: A Systematic Review and Meta-analysis

Background: Advanced glycation end products (AGE), one of the main factors causing diabetic end-organ damage, accumulate in long half-life proteins, such as skin and cartilage collagen. AGE measurement may offer additional evidence to predict diabetic vascular complications. Skin autofluorescence (S...

Full description

Bibliographic Details
Main Authors:	Mahboobeh sadat Hosseini, MD, Zahra Razavi, MD, Amir Houshang Ehsani, MD, Alireza Firooz, MD, Siamack Afazeli, Pharm.D.
Format:	Article
Language:	English
Published:	Elsevier 2021-12-01
Series:	EClinicalMedicine
Subjects:	Diabetes Mellitus Skin autofluorescence Advanced glycation end product Diabetic microvascular complication Diabetic macrovascular complication
Online Access:	http://www.sciencedirect.com/science/article/pii/S2589537021004752

Similar Items

Skin AGEs and diabetic neuropathy
by: Stella Papachristou, et al.
Published: (2021-02-01)

Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum?
by: Aastha Chawla, et al.
Published: (2016-01-01)

Adenosine Deaminase- Relation with Diabetes and its Complication
by: Saqib Hyder Shah, et al.
Published: (2020-10-01)

Significance of Hematological Parameters in Patients with Type-2 Diabetes Mellitus and Its Relationship with Disease Complications
by: Faraz Ali Rana, et al.
Published: (2023-02-01)

Greater macrovascular and microvascular morbidity from type 2 diabetes in northern compared with southern China: A cross‐sectional study
by: Li Wang, et al.
Published: (2020-09-01)

Comparison of the Risk Factors for Obstructive Sleep Apnoea between Type 1 and Type 2 Diabetes Patients: A Cross-Sectional Study Using the Diabetes Study from the Center of Tokyo Women's Medical University (DIACET) 2014
by: Zhuo Shen, et al.
Published: (2019-11-01)

Association of Secreted Frizzled Related Protein 4 with Type 2 Diabetes Mellitus and its complications: A South Indian hospital based case control study
by: Avivar Awasthi, MD, et al.
Published: (2021-01-01)

Measuring of Advanced Glycation End Products in Acute Stroke Care: Skin Autofluorescence as a Predictor of Ischemic Stroke Outcome in Patients with Diabetes Mellitus
by: Alexandra Filipov, et al.
Published: (2022-03-01)

Prevalence of Complications and Clinical Audit of Management of Type 2 Diabetes Mellitus: A Prospective Hospital Based Study
by: Malini Kulshrestha, et al.
Published: (2015-11-01)

Skin autofluorescence and the complexity of complications in patients with type 2 diabetes mellitus: a cross-sectional study
by: Xian Wang, et al.
Published: (2021-04-01)

Association of Serum Bilirubin Levels with Macro- and Microvascular Complications in Chinese People with Type 2 Diabetes Mellitus: New Insight on Gender Differences
by: Li S, et al.
Published: (2023-03-01)

Quantitative Color Fundus Autofluorescence in Patients with Diabetes Mellitus
by: Stela Vujosevic, et al.
Published: (2020-12-01)

Predominant Complications of Type 2 Diabetes in Kumasi: A 4-Year Retrospective Cross-Sectional Study at a Teaching Hospital in Ghana
by: Max Efui Annani-Akollor, et al.
Published: (2019-05-01)

Vascular Complication in Adolescents With Diabetes Mellitus
by: Lara E. Graves, et al.
Published: (2020-06-01)

Urinary 20-HETE: A prospective Non-Invasive prognostic and diagnostic marker for diabetic kidney disease
by: Pamela Houeiss, et al.
Published: (2023-02-01)

Description of a Cohort of Type 1 Diabetes Patients: Analysis of Comorbidities, Prevalence of Complications and Risk of Hypoglycemia
by: Antonio J. Martínez-Ortega, et al.
Published: (2022-02-01)

Diabetes in a hospital cohort of persons living with HIV: a descriptive and comparative study in French Guiana
by: Mathieu Nacher, et al.
Published: (2023-07-01)

Stem Cells for Diabetes Complications: A Future Potential Cure
by: Mogher Khamaisi, et al.
Published: (2017-01-01)

The skin autofluorescence may help to select patients with Type 2 diabetes candidates for screening to revascularization procedures
by: Fadi Alkhami, et al.
Published: (2024-01-01)

Association of Neutrophil Lymphocyte Ratio and Glycaemic Control in Patients with Type 2 Diabetes Mellitus
by: Pranathi Mahankali, et al.
Published: (2021-07-01)

Skin autofluorescence predicts major adverse cardiovascular events in patients with type 1 diabetes: a 7-year follow-up study
by: C. Blanc-Bisson, et al.
Published: (2018-06-01)

Healthcare Costs of Diabetes and Microvascular and Macrovascular Disease in Individuals with Incident Type 2 Diabetes Mellitus: A Ten-Year Longitudinal Study
by: Visaria J, et al.
Published: (2020-08-01)

Gut Microbiota and Complications of Type-2 Diabetes
by: Camelia Oana Iatcu, et al.
Published: (2021-12-01)

Diabetic Complications and Associated Factors: A 5-Year Facility-Based Retrospective Study at a Tertiary Hospital in Rwanda
by: Iradukunda A, et al.
Published: (2021-12-01)

Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study
by: C. R. L. Cardoso, et al.
Published: (2018-02-01)

Peripheral Arterial Diseases in Type 2 Diabetes Mellitus: A Cross-sectional Study Using Ankle-Brachial Index
by: Sunaya Chandrashekar, et al.
Published: (2018-01-01)

The Role of Advanced Glycation End Products in Diabetic Vascular Complications
by: Sang Youl Rhee, et al.
Published: (2018-05-01)

Skin Autofluorescence–Indicated Advanced Glycation End Products as Predictors of Cardiovascular and All‐Cause Mortality in High‐Risk Subjects: A Systematic Review and Meta‐analysis
by: Ivan Cavero‐Redondo, et al.
Published: (2018-09-01)

Effect of Clinical Inertia on Diabetes Complications among Individuals with Type 2 Diabetes: A Retrospective Cohort Study
by: Piranee Kaewbut, et al.
Published: (2021-12-01)

Macrovascular and renal microvascular complications in West Africans with intermediate hyperglycemia living in West Africa and Europe: The RODAM study
by: Emmanuel Bannerman-Williams, et al.
Published: (2023-08-01)

Continuous low serum levels of advanced glycation end products and low risk of cardiovascular disease in patients with poorly controlled type 2 diabetes
by: Tomoka Nakamura, et al.
Published: (2023-06-01)

Chronic kidney disease in patients with long-term type 1 diabetes mellitus
by: M. I. Yevloyeva, et al.
Published: (2023-12-01)

Effect of multidisciplinary intensive targeted care in improving diabetes mellitus outcomes: a randomized controlled pilot study – the Integrated Diabetes Education, Awareness and Lifestyle modification in Singapore (IDEALS) Program
by: Eberta Tan, et al.
Published: (2019-09-01)

Clinical audit on assessment of non-glycemic parameters in diabetic patients by physicians
by: S Ramya, et al.
Published: (2021-01-01)

Endogenous advanced glycation end products in the pathogenesis of chronic diabetic complications
by: Misganaw Asmamaw Mengstie, et al.
Published: (2022-09-01)

Clinical Implications of Glucose Variability: Chronic Complications of Diabetes
by: Hye Seung Jung
Published: (2015-06-01)

Genetic and Transcriptomic Background of Oxidative Stress and Antioxidative Therapies in Late Complications of Type 2 Diabetes Mellitus: A Systematic Review
by: Gašper Tonin, et al.
Published: (2024-02-01)

Role of advanced glycation end products in diabetic vascular injury: molecular mechanisms and therapeutic perspectives
by: Jing Liu, et al.
Published: (2023-12-01)

Potential benefit of (-)-epigallocatechin-3-gallate for macrovascular complications in diabetes
by: L. Tang, et al.
Published: (2017-08-01)

Diabetes mellitus and periodontal disease
by: Teodor Salmen, et al.
Published: (2021-12-01)